GlassScriptPhysician profile
Sean Robert Wilson
NPI 1275650640
$23,047.46
in general payments reported to CMS, 2019-2025
23 companies · $813 in 2025
The $813 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,111 · 2021: $1,298 · 2022: $2,208 · 2023: $1,953 · 2024: $3,767 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,199 · Travel and Lodging: $2,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,198.80 |
| Travel and Lodging | $2,334.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $7,374.23 | 2019 | |
| Abbott Laboratories | $5,194.44 | 2019-2025 | Cardiomems, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $2,499.28 | 2019-2024 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $2,336.51 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $2,054.40 | 2019-2020 | |
| Boston Scientific Corporation | $1,364.42 | 2019-2023 | Spyglass Discover |
| Medtronic, INC. | $571.49 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abiomed | $468.09 | 2019-2020 | |
| Zoll Circulation INC | $190.90 | 2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Depuy Synthes Sales INC. | $188.50 | 2019 | |
| Shockwave Medical, INC | $162.16 | 2025 | |
| Amarin Pharma, INC. | $109.69 | 2024 | |
| Janssen Pharmaceuticals, INC | $108.90 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $107.92 | 2019 | |
| Stryker Corporation | $89.08 | 2025 | Flowtriever |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $53.28 | 2020-2024 | Indigo System |
| Pfizer INC. | $29.32 | 2019-2020 | |
| Cardiva Medical, INC. | $28.91 | 2025 | Cardiva Vascade 5f Vcs |
| Chiesi USA, INC. | $27.95 | 2019 | |
| Heartflow, INC. | $27.85 | 2020 | |
| W. L. Gore & Associates, INC. | $24.64 | 2025 | Gore Cardioform Septal Occluder |
| Cardiovascular Systems INC. | $23.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.